KD Logo

Nektar Therapeutics [NKTR] Records 50-Day SMA of $1.0799

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nektar Therapeutics shares valued at $30,062 were sold by Wilson Mark Andrew on Dec 23 ’24. At $0.90 per share, Wilson Mark Andrew sold 33,402 shares. The insider’s holdings dropped to 351,892 shares worth approximately $0.32 million following the completion of this transaction.

Also, Wilson Mark Andrew sold 16,560 shares, netting a total of over 14,738 in proceeds. Following the sale of shares at $0.89 each, the insider now holds 335,332 shares.

Before that, Wilson Mark Andrew had added 16,560 shares to its account. In a trade valued at $14,801, the Officer bought Nektar Therapeutics shares for $0.89 each.

As published in their initiating research note from B. Riley Securities on January 08, 2025, Nektar Therapeutics [NKTR] has been a Buy and the price target has been revised to $4. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of November 04, 2024, Piper Sandler has initiated its “an Overweight” rating for NKTR.

Analyzing NKTR Stock Performance

During the last five days, there has been a drop of approximately -23.92%. Over the course of the year, Nektar Therapeutics shares have dropped approximately -2.66%. Shares of the company reached a 52-week high of $1.2500 on 01/07/25 and a 52-week low of $0.8712 on 01/14/25. A 50-day SMA is recorded $1.0799, while a 200-day SMA reached $1.2721. Nevertheless, trading volume fell to 1.34 million shares from 1.11 million shares the previous day.

Support And Resistance Levels for Nektar Therapeutics (NKTR)

According to the 24-hour chart, there is a support level at 0.8827, which, if violated, would cause prices to drop to 0.8601. In the upper region, resistance lies at 0.9452. The next price resistance is at 0.9851. RSI (Relative Strength Index) is 39.44 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0806, which suggests the price will decrease in the coming days. Percent R is at 91.00%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular